Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (474)	3/4/1999 9:27:00 PM
From: scaram(o)uche	Read Replies (3) of 4974

OK, lessee...... the news for the sector was obviously heavy on the negative side today...... SNAP and MAGN. I've never followed MAGN, and I don't know anyone that, to my knowledge, does. Hope nobody got hurt. SNAP, given the recent noise regarding acceleration of the plans for phase III, was an ugly blindside.... very un-SNAP like. On the positive side, we had the ABGX secondary at $45M for three million shares (btw..... ABGX adds 45M, and CEGE only adds 3.6M in market cap). That, plus the reagents ipo (Invitrogen) last week, indicates that the funding window has creaked open a tad. Another positive..... *congrats* to PDLI regarding Zenapax/European Union! Mike.... no matter how hype-prone the company, the science is respected..... Harley undoubtedly is a reviewer on most of the decent telomerase-related manuscripts that are submitted for editorial (peer) review. So.... we're looking for stuff to nominate for "major [positive] impact on the nature of the industry, going forward". We have nominations for GERN and AGPH. I won't be voting this evening.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next